Indisches Investorenkonsortium acquires Diatron MI
Haematology and clinical chemistry diagnostics · HUcarved out toIndisches InvestorenkonsortiumSTRATEC sells its subsidiary Diatron MI, with its haematology and clinical chemistry products, to an Indian investor consortium. The fixed purchase price is €10.0m, and closing is expected in the fourth quarter of 2026.
- Buyer
- Indisches Investorenkonsortium
- Target
- Diatron MI
- Seller
- STRATEC SE
- Type
- Carve-out
- Sector
- Healthcare & Medtech
- Country
- HU
- First reported
- 30/10/2026
- Source
- eqs-news.com
Deal-Radar no. 45-030 · added in Week 45/2026, first reported on 30/10/2026 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by Indisches Investorenkonsortium
So far this is the only transaction by Indisches Investorenkonsortium published in the Deal-Radar. New deals are added every Monday.
Acquisitions abroad in Week 45/2026
All deals in October 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 2 November 2026.